References
- Blom P.S., Querido A., Leeksma C.H.W. Acute leukemia following X-ray and radioiodine treatment of thyroid carcinoma. Br J Radiol 1955; 28: 165–166
- Seidlin S.M., Seigel E., Melamad S., Yallow A.A. Occurrence of myeloid leukemia in patients with metastatic thyroid carcinoma following prolonged massive radioiodine therapy. Bull NY Acad Med 1955; 31: 410
- Pochin E.E. Leukaemia following radioiodine treatment of thyrotoxicosis. Br Med J 1960; 2: 1545–1550
- Ozarda A., Ergin U., Bender M.A. Chronic myelogenous leukemia following I131 therapy for metastatic thyroid carcinoma. Am J Roentgeology, Radium Ther, Nuc Med 1961; 85: 914–918
- Pochin E.E. Prospects from the treatment of thyroid carcinoma with radioiodine. Clin Radiol 1967; 18: 113–115
- Brincker H., Hansen H.S., Anderson A.P. Induction of leukaemia by radioiodine treatment of thyroid carcinoma. Br J Cancer 1973; 28: 232–237
- Bundi R.S., Scott J.S., Hainan K.E. Chronic myeloid leukaemia following radioiodine therapy for carcinoma of the thyroid. Br J Radiol 1977; 50: 61–64
- Walgraeve D., Verhoef G., Stul M. Chronic myelogenous leukemia after treatment with 131I for thyroid carcinoma. Cancer Genet Cytogenet 1991; 55: 217–224
- Advani S.H., Hege U.P. Leukemia after 131I treatment of thyroid cancer-comments on the article “Second cancer following chemotherapy and radioiodine-an epidemiological perspective” by J Kaldor. Acta Oncol 1992; 31: 65
- Goldman M.B., Monson R.R., Maloof F. Cancer mortality in women with thyroid disease. Cancer Res 1990; 50: 2283–2289
- Hoffman D.A., McConahey W.M., Fraumeni J.F., Kurland L.T. Cancer incidence following treatment of hyperthyroidism. Int J Epidemiol 1982; 11: 218–224
- Saenger E.L., Thoma G.E., Tompkins E.A. Incidence of leukemia following treatment of hyperthyroidism. Preliminary report for the cooperative Thyrotoxicosis Therapy Follow-Up Study. JAMA 1968; 205: 855–62
- Edmonds C.J., Smith T. The long-term hazards of treatment of thyroid cancer with radioiodine. Br J Radiol 1986; 59: 45–51
- Hall P., Holm L.-E., Lundell G. Cancer risks in thyroid cancer patients. Br J Cancer 1991; 64: 159–163
- Holm L.-E., Hall P., Wiklund K. Cancer risk after iodine-131 therapy for hyperthyroidism. JNCI 1991; 83: 1072–1077
- Hall P., Berg G., Bjelkengren G. Cancer mortality after iodine-131 therapy for hyperthyroidism. Int J Cancer 1992; 50: 886–890
- Hall P., Boice J.D., Berg G. Leukaemia incidence after iodine-131 exposure. Lancet 1992; 340: 1.4
- Britton R., Sachmechi I., Benegalrao Y., Schneider B.S. Leukemia after a small dose of radioiodine for metastatic thyroid cancer. J Clin Endocrinol Metab 1993; 77: 1423–6
- Stavem P., Van der Hagen C.B., Vogt E., Surdnes K. Polycythemia vera treated with 32P and myleran: development of abnormalities in one patient. Clin Genet 1975; 7: 227–31
- Lipton J.H., Messner H.A. Chronic myeloid leukemia in a woman with Still's disease treated with 198Au synoviorthesis. J Rheumatol 1991; 18: 745–5